A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic ObstructiveInterventions: Drug: UMEC DPI; Drug: Placebo DPI; Drug: ICS/LABA medication; Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor: GlaxoSmithKlineNot yet recruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials